Herpes Zoster Podcasts: Recent Episodes
medthority
Join herpes zoster experts in this podcast series discussing the epidemiology of herpes zoster, herpes zoster-associated pain, and management of this condition in immunocompromised patients.
Developed by EPG Health for Medthority. This Herpes Zoster Podcast Series was developed with the support of GlaxoSmithKline Biologicals SA (GSK). EPG Health retains final responsibility for the editorial content. EPG Health received medical educational funding from GSK in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
Some products mentioned in this Podcast may not be available in your country, and prescribing information may vary from country to country. Please check local prescribing information if required.
This podcast is intended for registered Healthcare Professionals only.
The final Podcast in this series, Professor Cunningham and Professor Diez-Domingo examine which immunocompromised patient populations may be considered for herpes zoster vaccination, considering the type of vaccine, severity of their condition and other individual factors such as concomitant medications. They also discuss evidence on the risk of disseminated herpes zoster, hospitalisation, and death in immunocompromised patients, and the critical clinical objectives for managing herpes zoster in this patient population.
Listen to insights from Professor Cunningham and Professor Diez-Domingo on the topic of herpes zoster-associated pain. In this second podcast of this series, these experts discuss the distinction between prodromal acute, subacute, and chronic pain associated with herpes zoster, and the burden of herpes zoster-associated pain, including post-herpetic neuralgia (PHN), on patient quality of life. They also discuss the impact of vaccination on herpes-zoster associated pain and PHN.
In this first podcast of this series, we explore the global prevalence and incidence of herpes zoster. Join Professor Anthony Cunningham (Director, Australian Centre for HIV and Hepatitis Virology Research [ACH2], Australia) and Professor Javier Diez-Domingo (Foundation for the Promotion of Health and Biomedical Research [FISABIO], Spain) as they review the limitations of epidemiologic studies on herpes zoster and their effect on subsequent vaccine effectiveness studies. They also discuss the global incidence, hospitalisation, and mortality rates of herpes zoster in older adults, among other topics.